A 50-year-old Japanese female with a long history of Raynaud's phenomenon presented with progressive dyspnea due to pulmonary hypertension. The diagnosis of systemic lupus erythematosus was confirmed by proteinuria, lymphocytopenia, bilateral pleurisy, and a seizure of convulsion which wasconsistent with neurological manifestations of systemic lupus erythematosus, whereas the antinuclear antibody showed a low titer. Despite improvement in the activity of systemic lupus erythematosus, steroid treatment did not alter the progression of pulmonary hypertension, which increased in severity, eventually resulting in her death. We believe pulmonary hypertension to be an unusual but critical complication of systemic lupus erythematosus.
Introduction
Pulmonary hypertension (PH) is one of the morerare complications in patients with systemic lupus erythematosus (SLE) (1) . The pathophysiology of PH is unknown, and in many patients the condition generally carries a poor prognosis despite treatment, sometimes following a rapidly progressive course leading to right-sided heart failure and death (2) . We describe a case of SLEwith supervening PH, who developed right-sided heart failure and respiratory failure with poor response to treatment.
Case Report A50-year-old Japanese female wasadmitted to our hospital on October 30, 1993 because of progressive dyspnea on exertion and worsening fatigue. She had a long history ofRaynaud' s phenomenon for 32 years, and recurrent digital gangrene of both hands had supervened from 198 1 , which had been treated in the department of dermatology of our hospital. In 1988 and 1993 routine chest X-ray films showed increasingly accentuated central pulmonary vasculature with peripheral pruning, with some prominence of the right ventricle and clear lungs.
Consecutive electrocardiograms (Fig. 1 ) disclosed increased anterior R-wave voltage with right bundle branch block, consistent with right ventricular enlargement. These findings suggested progressing pulmonary hypertension, but no further investigations were performed. She also had a self-limiting illness with edema, occasional proteinuria, and episodic dyspnea on exertion from 1992, which became worse gradually. She had not been suffering from photosensitivity, alopecia, oral ulcers, or rashes. She was a nonsmokerand had no history of taking oral contraceptive drugs and had no history of deep vein thrombosis; she had never been pregnant. She did not have proceeding fever, arthralgia, and pleural chest pain.
For editorial comment, see pi Physical examination on admission disclosed a cooperative, thin female with a normal temperature and a pulse rate of 84 beats/min. Her blood pressure was 138/80 mmHg. She was noted to have peripheral cyanosis, a loud pulmonary component of the second heart sound, a palpable liver descending 9 cm below the right costal arch, and peripheral edema. There were no rales over the lung fields and no findings of a nd 3+ oc c ul t bl ood wi t hout a ny c e l l ul a r c a s t s .
The s e dime nt a t i on r a t e wa s 21 mm/ h. The SGOT, SGPT, LDH, a nd c r e a t i n i n e l e v e l s w e r e n o r m a l . T h e a l b u m i n a n d g a m m a g l o b ul i n c o n c e n t r a t i o n s w e r e 2 . 4 g / d l a n d 1 . 6 g / d l , r e s p e c t i v e l y ,
C o m p l e m e n t s t u d i e s r e v e a l e d a n o r ma l CH5 0 l e v e l o f 4 0 . 6 U / m l . Th e a n t i n uc l e a r a n t i b o d y ( A N A ) t i t e r w a s 1 : 4 0 ( u n d e t e r m i n e d p a t t e r n ) , a n d t h e o t h e r a u t o a n t i b o d i e s , s u c h a s a n t i -U l s n r i b o n u c l e o p r ot e i n ( R N P ) a n t i b o d y , a n t i -d o u b l e s t r a n d d e o x y r i b o n u c l e i c a c i d ( DNA) a nt i body, a nt i -Sm a nt i body, a nd r he uma t oi d f a c t or , w e r e n o t d e t e c t e d . L u p u s a n t i c o a g u l a n t ( L A C ) a n d a n t i -c a r d i -o l i p i n a n t i b o d y w e r e a l s o n e g a t i v e . A r t e r i a l b l o o d g a s a n a l y s i s r e v e a l e d P a O 2 5 0 . 0 T o r r , P a C O 2 2 6 . 7 T o r r , a n d p H 7 . 5 0 o n r o o m a i r . C h e s t r a d i o g r a p h y ( F i g . 2 ) d e m o n s t r a t e d b i l a t e r a l p l e u r a ! e f f u s i o n w i t h o u t s i g n i f i c a n t p a r e n c h y m a l d i s e a s e i n t h e l u n g s .
E c h o c a r d i o g r a p h y ( F i g . 3 ) s h o w e d e n l a r g e m e n t o f r i g h t v e n t r i c l e a n d r i g h t a t r i u m , a n d p u l m o n a r y a r t e r y s y s t o l i c p r e ss ur e was es t i mat ed t o be about 87 mmHg whi ch was cal cul at ed f r om t he s um of t he pe a k t
T h e r e w a s n o l e f t t o r i g h t s h u n t . P e r f u s i o n l u n g s c a n w a s n o r m a l .
S 
Discussion
PH is considered a rare pulmonary complication of SLE although a prevalence of0.5% to 9% has been reported (3). PH may occur as a result of significant parenchymatous disease in the lungs or secondary to a cardiac disorder such as a left to right shunt, howeversuch a condition of lungs and heart was not found in the present patient. The most commonassociation of PHin collagen vascular disease has been with mixed connective tissue disease and scleroderma, particularly in the CREST variety, but it has been increasingly reported in SLE (4) . PH association with SLEmay have a relentlessly progressive course with a variable response to treatment and a generally poor prognosis (5); death within two years is the rule (1). Asherson and coworkers (2) report that symptoms of PH occur within three months to 1 1 years after the diagnosis of SLE has been made. The average time for the development of PHis between two and five years in most of the patients, and the cause of death is sudden, usually from end-stage circulatory collapse (2) , which also developed in our patient. The incidence of hypertensive pulmonary vascular disease is not reflected to the severity or activity of SLE itself such as high anti-DNA binding values and/or grossly elevated erythrocyte sedimentation rates ( 1), but is often associated with the presence ofanti-Ul sn RNP antibody, rheumatoid factor and LAC (6) . Various theories as to the pathogenesis of PHin SLEhave been proposed, such as thrombo-embolic disease, vasoconstriction of the pulmonary arteries, immunecomplex vasculitis, and interstitial pneumonia (5). It has been also noted that LAC as well as anticardiolipin antibodies are found in SLE associated with PH, although these were absent in our patient. An increased frequency of Raynaud's phenomenon in the condition suggests that a vasospastic factor plays an important role in the etiopathogenesis (2); the frequency ofRaynaud' s phenomenon in SLE is about 25%, while it is present in 75-80% of the patients with PH-associated SLE (7, 8) . In our patient, Raynaud's phenomenon antedated the onset of PHby a numberof years, leading to gangrene of the fingers. Anautopsied case of SLE with PH shows hypertrophy of the smaller muscular pulmonary arteries, marked thickening of the intima by cellular fibromuscular tissue and plexiform lesions (9) . It is possible that chronic "pulmonary Raynaud's phenomenon" can lead to chronic PH in some patients with SLE (10). The prognosis of PHis poor and once established, heart/lung transplantation may be the only effective therapy (9) . Irreversible changesin the resistance vessels are no longer capable of dilatation even with vasodilator agents (1) . At an early stage in the course of PH, increased pulmonary vasomotor tone and reactivity may permit a beneficial pulmonary vasodilator response to these agents (1). As supervening PH should always be considered in patients with SLE, serial Doppler echocardiography is necessary for routine screening in order to detect these early preclinical stages and the development of PH (7) .
